Amrutanjan Health Care's Q1 Financial Results Show Negative Trend, MarketsMOJO Gives 'Hold' Call

Amrutanjan Health Care, a smallcap pharmaceutical company, has recently declared its financial results for the quarter ending June 2024. According to the latest report, the company's financial performance has been negative, with a score of -11 compared to 7 in the previous quarter.

The company's Profit Before Tax (PBT) has fallen by 66.90% Year on Year (YoY) to Rs 1.90 crore, indicating a very negative trend in the near term. Similarly, the Profit After Tax (PAT) has also decreased by 34.1% YoY to Rs 4.62 crore, with a negative trend in the near term. The Operating Profit (PBDIT) has reached its lowest point in the last five quarters at Rs 3.56 crore, showing a negative trend in the near term. The Operating Profit Margin has also decreased to its lowest point at 4.25%, indicating a deterioration in the company's efficiency.

Moreover, the Non-Operating Income is 70.08% of the Profit Before Tax (PBT), which suggests that the company's income from non-business activities is high and not sustainable in the long run. The Earnings per Share (EPS) has also decreased to its lowest point at Rs 1.60 in the last five quarters, indicating a decline in profitability and lower earnings for shareholders.

Based on these financial results, MarketsMOJO has given a 'Hold' call for Amrutanjan Health Care's stock. The company's financial performance in the quarter ending June 2024 has not been favorable, and it is important for investors to carefully consider their options before making any decisions.